The Dec 2023 issue of JLB contains a cluster of articles related to the Neutrophil 2022 meeting. A few more articles will follow in the Feb 2024 issue. The publisher will then create an online collection comprising all papers.

JLB Dedicated Online Collection

Be a part of a Special JLB Online Collection for N2024-related papers!

The Journal of Leukocyte Biology (JLB, see website) will publish a cluster of articles related to topics of the Neutrophil 2024 meeting – both review papers and original investigations. Selected contributions will be invited soon after the completion of the conference, and all submitted manuscripts will be peer-reviewed according to the high standards of the JLB.

The JLB publishes original experimental and clinical research that provides new insights into the function of leukocytes and/or stromal cells at the molecular, structural, cellular and systemic level.  The Journal scope includes all leukocytes (granulocytes, monocytes/macrophages, dendritic cells, T, B and innate lymphoid or NK/NKT cells) and/or leukocyte products together with associated stromal (endothelial, epithelial) cells studied in vitro and in the context of innate and adaptive immunity, development, homeostasis, host-pathogen interactions, immunotherapy and immunopathogenesis (in both vertebrate models and/or human studies).  Pathologies of interest include immunodeficiency, autoimmunity, allergy, cancer, trauma, infections, inflammatory and iatrogenic diseases. JLB also publishes basic, translational and clinical reviews as well as commentaries on current journal content.

Participants may submit their work for the dedicated issue according to the following schedule. When submitting, please include the name of the meeting in your cover letter.


  • Neutrophil 2024 meeting – Sept 17-19, 2024
  • Invite: October 18, 2024
  • Respond by: November 30, 2024
  • Submit by: Jan 31, 2025
  • Review by: March 30, 2025
  • Revise by: July 1, 2025
  • Re-Review by: September 1, 2025
  • ACCEPT by: September 15, 2025
  • PUBLISH: January 1, 2026